Peripheral blood stem cell mobilization in multiple myeloma: Growth factors or chemotherapy?

about

Peripheral blood stem cell mobilization in multiple myeloma: Growth factors or chemotherapy?

Item

http://www.wikidata.org/entity/Q45735258

description

2017 nî lūn-bûn

@nan

2017 թվականի հոկտեմբերին հրատարակված գիտական հոդված

@hy

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

name

Peripheral blood stem cell mob ...... rowth factors or chemotherapy?

@en

Peripheral blood stem cell mob ...... rowth factors or chemotherapy?

@nl

type

Item

label

Peripheral blood stem cell mob ...... rowth factors or chemotherapy?

@en

Peripheral blood stem cell mob ...... rowth factors or chemotherapy?

@nl

prefLabel

Peripheral blood stem cell mob ...... rowth factors or chemotherapy?

@en

Peripheral blood stem cell mob ...... rowth factors or chemotherapy?

@nl

P1476

Peripheral blood stem cell mob ...... rowth factors or chemotherapy?

@en

P2093

Muzaffar H Qazilbash

http://www.w3.org/2001/XMLSchema#string

Whitney D Wallis

http://www.w3.org/2001/XMLSchema#string

P2860

Cytokines and hematopoietic stem cell mobilization

Synergistic effects between GM-CSF and G-CSF or M-CSF on highly enriched human marrow progenitor cells.

Hematopoietic rescue after high-dose chemotherapy using autologous peripheral-blood progenitor cells or bone marrow: a randomized comparison.

Treatment of normal individuals with granulocyte-colony-stimulating factor: donor experiences and the effects on peripheral blood CD34+ cell counts and on the collection of peripheral blood stem cells.

Comparison of high-dose CY and growth factor with growth factor alone for mobilization of stem cells for transplantation in patients with multiple myeloma.

High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma.

Antigenic analysis of hematopoiesis. III. A hematopoietic progenitor cell surface antigen defined by a monoclonal antibody raised against KG-1a cells.

Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist

The whys and hows of hematopoietic progenitor and stem cell mobilization.

Impairment of filgrastim-induced stem cell mobilization after prior lenalidomide in patients with multiple myeloma.

P304

250-259

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.5500/WJT.V7.I5.250

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29104859

http://www.w3.org/2001/XMLSchema#string

P932

5661122

http://www.w3.org/2001/XMLSchema#string